https://www.thebodypro.com/slideshow/is-the-world-ready-for-long-acting-hiv-treatment
HIV Policy and Advocacy

Is the World Ready for Long-Acting HIV Treatment?

VIEW AS: LIST | SLIDES
globe, syringe, and pills
gmutlu via iStockphoto

Carl W. Dieffenbach, Ph.D.
Carl W. Dieffenbach, Ph.D., courtesy of NIAID

What Problems Does LA-ART Solve?


Rendering of pipelines
tovovan for iStock via Thinkstock

A Robust LA-ART Pipeline


Slide from Summit presentation
Carl W. Dieffenbach, Ph.D. 2018 Controlling the HIV Epidemic Summit; Long-Acting Antivirals -- Where Are We Headed? Are We Ready? Reprinted with permission.

LA-ART Trials of the Past


Slide from Summit presentation
Adapted from Carl W. Dieffenbach, Ph.D. 2018 Controlling the HIV Epidemic Summit; Long-Acting Antivirals -- Where Are We Headed? Are We Ready?

Present and Future LA-ART Trials


A person receiving an injection
wissanu01 via iStockphoto

The Bottom Line on LA-ART's Potential


Myles Helfand

Myles Helfand

@MylesatTheBody

Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro.